Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension
Am. Pellizzer et al., Comparative effects of mibefradil and nifedipine gastrointestinal transport system on autonomic function in patients with mild to moderate essential hypertension, J HYPERTENS, 19(2), 2001, pp. 279-285
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background L-type dihydropyridine calcium channel blockers (CCBs) have been
implicated in increased cardiovascular events in patients with hypertensio
n, perhaps due to adverse effects on autonomic nervous system (ANS) functio
n. Blockade of T-type calcium channels may limit ANS dysfunction by inhibit
ion of T channel-mediated neuroendocrine effects.
Objective and design This double-blind, parallel group study compared the e
ffect of nifedipine gastrointestinal transport system (GITS) (L-type CCB) v
ersus mibefradil (T-type CCB) on ANS function in patients with mild-moderat
e essential hypertension.
Methods Sixteen patients (10 male, 6 female; age 51.2 +/- 2.3 years), diast
olic blood pressure (DBP) < 95 mmHg were randomized to nifedipine 30 mg dai
ly or mibefradil 50 mg daily (2 weeks), then nifedipine 60 mg daily or mibe
fradil 100 mg daily (4 weeks). Sympathetic nervous system activity (SNSA) w
as assessed using norepinephrine kinetics. Parasympathetic nervous system a
ctivity (PSNA) was assessed from 24 h Holter recordings of heart rate varia
bility (HRV). Non-invasive baroreflex sensitivity (BRS) provided integrated
assessment of ANS,
Results Patient groups were well matched at baseline. Achieved DBP was lowe
r in patients treated with mibefradil compared with nifedipine, (83.4 +/- 1
,7 versus 95.25 +/- 3.3 mmHg). There were no significant differences in SNS
A and BRS between groups, however the root mean square of successive differ
ences and high frequency power (HFP) were increased in mibefradil compared
with nifedipine-treated patients [(+ 1.07 +/- 1.6 versus -3.36 +/- 1.2 ms,
P < 0.05) and (+ 0.28 +/- 0.1 versus -0.23 +/- 0.1 ms(2), P < 0.01), respec
tively]. Furthermore, Ln HFP/Ln total power was increased from week 0 to we
ek 6 in the mibefradil-treated group, (0.71 +/- 0.02 versus 0.74 +/- 0.03,
P = 0.046).
Conclusion No differences existed between effect of Land T-type CCBs on SNS
A and BRS. However, T-type CCBs increased PSNA, independent of achieved cha
nges in heart rate. (C) 2001 Lippincott Williams & Wilkins.